NCT06670495 HPV Genotype Attribution and Disease Burden of Anal Cancer in China
| NCT ID | NCT06670495 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fudan University |
| Condition | Anal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2025-06-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To demonstrate HPV prevalence and its genotype distributions in anal cancer in China and to describe demographic and clinical features of HPV-related anal cancer in China; To describe the epidemiological characteristics ,trends and of disease burden of anal cancer in China
Eligibility Criteria
Inclusion Criteria: * (1) Patients diagnosed with anal cancers, (2) Patients without radiation or chemotherapy prior to specimen collection; Exclusion Criteria: * (1) Patients with HIV infection, (2) Patients with immunosuppression after solid organ transplantation, (3) Those who do not agree to specimen collection and testing, (4) For retrospective study cases, those who without specimen.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06670495 clinical trial?
This trial is open to participants of all sexes, studying Anal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06670495 currently recruiting?
Yes, NCT06670495 is actively recruiting participants. Contact the research team at zhengying@fudan.edu.cn for enrollment information.
Where is the NCT06670495 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT06670495 clinical trial?
NCT06670495 is sponsored by Fudan University. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.